It’s a case of so far, so good for Ipsen with its recent acquisition of Albireo, after the main asset in the deal – Bylvay – secured FDA approval for its second rare disease indication. The US ...
In unusual circumstances, Ipsen has been given the green light for its odevixibat drug for severe itching (pruritus) in patients with rare liver disease Alagille syndrome (ALGS) in the EU – for the ...
According to DelveInsight's analysis, the primary sclerosing cholangitis market is anticipated to grow during the forecast period (2025--2034), driven by the launch of emerging therapies such as LB-P8 ...
German shipping firms Harren Group and NSB Group are pooling their ship management and crewing expertise through Albireo, a new joint-venture manning agent in Manila, aimed at strengthening support ...
Start order revealed for 2026 DBSC Spring Chicken Series, kicking off 1 February in Dublin Bay with 40 boats entered.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results